Swiss Nash Foundation

Founded in October 2019

The Swiss NASH Foundation was launched in October 2019 in Bern, Switzerland. In a joint effort to tackle the prevalence and burden of NASH, scientific experts and the leading pharmaceutical companies: Gilead, Allergan, Genfit and Intercept have joined forces to establish the foundation.

Swiss NASH Day

Swiss NASH Day is dedicated to increasing awareness about NASH and is scheduled the same week as the international NASH day. The Swiss NASH foundation is organising an event that will bring together different scientific and medical experts to discuss the latest advances in NASH research, treatment and patient management.

The Swiss NASH Foundation’s mission and goals

What is NASH?

Non-alcoholic steatohepatitis (NASH) is the consequence of abnormal fat accumulation in the liver leading to liver inflammation and damage. It is the most severe form of non-alcoholic liver disease (NAFLD), commonly called “fatty liver”. NASH is a worldwide epidemic disease affecting over 115 million people. Still, NASH remains an under-diagnosed and consequently an underreported disease.

Find out more >

Living with NASH

Many people live with NASH without knowing that they have a liver disease. The quality of life of these persons might be reduced due to their liver condition. Lifestyles can do a lot to improve NASH. Changes in diet habits, regular physical activity are measures which can improve if not cure NASH.